Genetic Info is Less Valuable Than Social and Search Data

GlaxoSmithKline has invested $300 million into 23andMe. GSK and 23andMe will partner to develop new medicines. They will split costs and profits equally. 23andMe raised $250 million at a $1.75...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]